| Date Filed | Type | Description |
| 10/06/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Sold 38,548 shares
@ $0.8407, valued at
$32.4k
Exercised 38,548 options to buy
@ $0.42, valued at
$16.2k
|
|
| 08/25/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Sold 40,894 shares
@ $1.0544, valued at
$43.1k
Exercised 40,894 options to buy
@ $0.42, valued at
$17.2k
|
|
| 08/22/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.14, valued at
$5.3k
|
|
| 08/22/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 6,209 shares
@ $1.14, valued at
$7.1k
|
|
| 08/22/2023 |
4
| Richards William G (Head of Therapeutics Discovery) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 8,185 shares
@ $1.14, valued at
$9.3k
|
|
| 08/16/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Sold 40,894 shares
@ $1.319, valued at
$53.9k
Exercised 40,894 options to buy
@ $0.42, valued at
$17.2k
|
|
| 08/11/2023 |
3
| Richards William G (Head of Therapeutics Discovery) has filed a Form 3 on 23andMe Holding Co. |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Sold 40,894 shares
@ $1.7223, valued at
$70.4k
Exercised 40,894 options to buy
@ $0.42, valued at
$17.2k
|
|
| 06/07/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 43,659 shares
@ $0
Paid exercise price by delivering 15,098 shares
@ $2.08, valued at
$31.4k
|
|
| 06/07/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 44,381 shares
@ $0
Paid exercise price by delivering 15,347 shares
@ $2.08, valued at
$31.9k
|
|
| 06/07/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 37,808 shares
@ $0
Paid exercise price by delivering 13,075 shares
@ $2.08, valued at
$27.2k
|
|
| 05/23/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 6,209 shares
@ $1.94, valued at
$12k
|
|
| 05/23/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.94, valued at
$9k
|
|
| 05/23/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.94, valued at
$9k
|
|
| 02/22/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 5,457 shares
@ $2.87, valued at
$15.7k
|
|
| 02/22/2023 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 7,321 shares
@ $2.87, valued at
$21k
|
|
| 02/22/2023 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 5,457 shares
@ $2.87, valued at
$15.7k
|
|
| 12/06/2022 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Sold 26,259 shares
@ $3.25, valued at
$85.3k
|
|
| 11/22/2022 |
4
| Selsavage Joseph Anthony (Interim CFO) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 10,105 shares
@ $2.99, valued at
$30.2k
|
|
| 11/22/2022 |
4
| HIBBS KATHY L (Chief Administrative Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $2.99, valued at
$13.8k
|
|
| 11/22/2022 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $2.99, valued at
$13.8k
|
|
| 11/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Hernandez Sandra R MD (Director) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 14,633 shares
@ $0
Granted 3,251 shares
@ $3.08, valued at
$10k
|
|
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/29/2022 |
4
| Hernandez Sandra R MD (Director) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 57,755 shares
@ $0
Granted 13,201 shares
@ $3.03, valued at
$40k
|
|
|